FDA
-
-
-
-
-
-
-
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
-
-
-
-
-
-
-
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
-
-
-
-
-
-
-
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
-
-
-
-
-
-
Lifeward enters $47 million strategic partnership with Oramed
-
-
-
-
-
-
-
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
-
-
-
-
-
-
-
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Lifeward (LFWD) Names Mark Grant as New CEO
-
330,011 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

